Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study

NACompletedINTERVENTIONAL
Enrollment

499

Participants

Timeline

Start Date

October 27, 2015

Primary Completion Date

August 19, 2016

Study Completion Date

March 21, 2017

Conditions
Heart Failure
Interventions
DEVICE

Quartet 1457Q LV Lead

Trial Locations (30)

17602

Lancaster General Hospital, Lancaster

18840

Donald Guthrie Foundation for Education & Research, Sayre

27103

Forsyth Medical Center, Winston-Salem

29605

Greenville Health System, Greenville

30322

Emory University Hospital, Atlanta

30501

North Georgia Heart Foundation, Gainesville

32308

Tallahassee Research Institute, Tallahassee

34471

Munroe Regional Medical Center, Ocala

35801

Heart Center Research, Huntsville

37403

Erlanger Medical Center, Chattanooga

38138

The Stern Cardiovascular Foundation, Germantown

40503

Central Baptist Hospital, Lexington

42304

One Health Cardiology, Owensboro

44106

University Hospitals of Cleveland, Cleveland

48912

Thoracic Cardiovascular Healthcare Foundation, Lansing

50266

Iowa Heart Center, West Des Moines

53715

St. Mary's Hospital, Madison

65201

Missouri Heart Center, Columbia

72401

Cardiology Associates of Northeast Arkansas, Jonesboro

74104

Oklahoma Heart Institute at Utica, Tulsa

75093

The Heart Hospital Baylor Plano, Plano

85013

Arizona Arrhythmia Research Center, Phoenix

92037

Scripps Health, La Jolla

92663

Premier Cardiology, Inc., Newport Beach

94305

Stanford University Hospital, Stanford

98122

Swedish Medical Center - Heart & Vascular, Seattle

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

03102

Catholic Medical Center, Manchester

08035

Cardiovascular Associates of Delaware Valley, Haddon Heights

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY